Thromboembolic risk with gender-affirming hormone therapy: potential role of global coagulation and fibrinolysis assays.

Bouck, Emma G; Grinsztejn, Eduarda; Mcnamara, Megan; Stavrou, Evi X; Wolberg, Alisa S

Bouck, Emma G; Grinsztejn, Eduarda; Mcnamara, Megan; Stavrou, Evi X; Wolberg, Alisa S.

Afiliação

Bouck EG; Department of Pathology and Laboratory Medicine and UNC Blood Research Center, University of North Carolina, Chapel Hill, NC, USA.
Grinsztejn E; Department of Medicine, Hematology and Oncology Division, University Hospitals Cleveland Medical Center, Cleveland, OH, USA.
Mcnamara M; Medicine Service, Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, USA.
Stavrou EX; Department of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Wolberg AS; Medicine Service, Section of Hematology-Oncology, Louise Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH, USA.

Res Pract Thromb Haemost ; 7(6): 102197, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37822706

Palavras-chave

estrogens; fibrinolysis; risk factors; thrombosis; transgender

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google